,Gene_symbo,HPO_en,HPO_ch
0,LOC111365204,Peripheral retinal atrophy (HP:0200070);Visual impairment (HP:0000505);Chorioretinal atrophy (HP:0000533);Visual field defect (HP:0001123);Abnormality of eye movement (HP:0000496);Retinal atrophy (HP:0001105);Abnormality of the urinary system physiology (HP:0011277);Abnormality of the urinary system (HP:0000079);Abnormal macular morphology (HP:0001103);Abnormality of the eye (HP:0000478);Abnormal retinal morphology (HP:0000479);Abnormal posterior eye segment morphology (HP:0004329);Nystagmus (HP:0000639);Abnormality of metabolism/homeostasis (HP:0001939);Retinal dystrophy (HP:0000556);Yellow/white lesions of the retina (HP:0030506);Abnormal chorioretinal morphology (HP:0000532);Aminoaciduria (HP:0003355);Scotoma (HP:0000575);Generalized aminoaciduria (HP:0002909);Abnormal eye morphology (HP:0012372);Abnormal urine metabolite level (HP:0033354);Abnormal involuntary eye movements (HP:0012547);Retinal degeneration (HP:0000546);Drusen (HP:0011510);Abnormal choroid morphology (HP:0000610);Abnormal eye physiology (HP:0012373);Abnormal fundus morphology (HP:0001098);Central scotoma (HP:0000603);Abnormality of vision (HP:0000504);Abnormal uvea morphology (HP:0000553);Chorioretinal dystrophy (HP:0001135);Abnormality of macular pigmentation (HP:0008002);Myopia (HP:0000545);Macular dystrophy (HP:0007754);Chorioretinal degeneration (HP:0200065);Abnormality of the genitourinary system (HP:0000119);Abnormality of urine homeostasis (HP:0003110);Reduced visual acuity (HP:0007663);Abnormality of refraction (HP:0000539);Retinal detachment (HP:0000541);Autosomal dominant inheritance (HP:0000006),Peripheral retinal atrophy (HP:0200070);Visual impairment (HP:0000505);Chorioretinal atrophy (HP:0000533);Visual field defect (HP:0001123);Abnormality of eye movement (HP:0000496);Retinal atrophy (HP:0001105);Abnormality of the urinary system physiology (HP:0011277);Abnormality of the urinary system (HP:0000079);Abnormal macular morphology (HP:0001103);Abnormality of the eye (HP:0000478);Abnormal retinal morphology (HP:0000479);Abnormal posterior eye segment morphology (HP:0004329);Nystagmus (HP:0000639);Abnormality of metabolism/homeostasis (HP:0001939);Retinal dystrophy (HP:0000556);Yellow/white lesions of the retina (HP:0030506);Abnormal chorioretinal morphology (HP:0000532);Aminoaciduria (HP:0003355);Scotoma (HP:0000575);Generalized aminoaciduria (HP:0002909);Abnormal eye morphology (HP:0012372);Abnormal urine metabolite level (HP:0033354);Abnormal involuntary eye movements (HP:0012547);Retinal degeneration (HP:0000546);Drusen (HP:0011510);Abnormal choroid morphology (HP:0000610);Abnormal eye physiology (HP:0012373);Abnormal fundus morphology (HP:0001098);Central scotoma (HP:0000603);Abnormality of vision (HP:0000504);Abnormal uvea morphology (HP:0000553);Chorioretinal dystrophy (HP:0001135);Abnormality of macular pigmentation (HP:0008002);Myopia (HP:0000545);Macular dystrophy (HP:0007754);Chorioretinal degeneration (HP:0200065);Abnormality of the genitourinary system (HP:0000119);Abnormality of urine homeostasis (HP:0003110);Reduced visual acuity (HP:0007663);Abnormality of refraction (HP:0000539);Retinal detachment (HP:0000541);Autosomal dominant inheritance (HP:0000006);眼底异常(HP:0001098);眼部异常(HP:0000478);泌尿生殖系统异常(HP:0000119);泌尿系统异常(HP:0000079);周边视网膜萎缩(HP:0200070);屈光异常(HP:0000539);中心暗点(HP:0000603);视力异常(HP:0000504);脉络膜异常(HP:0000610);眼后段的异常(HP:0004329);眼球震颤(HP:0000639);脉络膜视网膜异常(HP:0000532);视网膜脉络膜变性(HP:0200065);黄斑异常(HP:0001103);尿稳态平衡异常(HP:0003110);脉络膜视网膜营养不良(HP:0001135);葡萄膜异常(HP:0000553);视网膜黄/白病变(HP:0030506);泌尿系统生理异常(HP:0011277);视网膜脱离(HP:0000541);代谢紊乱/稳态失衡(HP:0001939);黄斑色素沉着异常(HP:0008002);眼部生理异常(HP:0012373);眼部形态异常(HP:0012372);眼球运动异常(HP:0000496);视觉障碍(HP:0000505);脉络膜视网膜萎缩(HP:0000533);黄斑营养不良(HP:0007754);玻璃膜疣(HP:0011510);视网膜变性(HP:0000546);视网膜萎缩(HP:0001105);全谱氨基酸尿(HP:0002909);盲点(HP:0000575);不自主眼球运动异常(HP:0012547);视网膜的异常(HP:0000479);近视(HP:0000545);中心视力下降(HP:0007663);视野缺损(HP:0001123);视网膜营养不良(HP:0000556);氨基酸尿(HP:0003355);常染色体显性遗传(HP:0000006)
